F. Léger

586 total citations
11 papers, 476 citations indexed

About

F. Léger is a scholar working on Oncology, Pharmacology and Molecular Biology. According to data from OpenAlex, F. Léger has authored 11 papers receiving a total of 476 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Oncology, 4 papers in Pharmacology and 3 papers in Molecular Biology. Recurrent topics in F. Léger's work include Antibiotics Pharmacokinetics and Efficacy (4 papers), Cancer therapeutics and mechanisms (3 papers) and Renal Transplantation Outcomes and Treatments (3 papers). F. Léger is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (4 papers), Cancer therapeutics and mechanisms (3 papers) and Renal Transplantation Outcomes and Treatments (3 papers). F. Léger collaborates with scholars based in France, Netherlands and Germany. F. Léger's co-authors include C. Puozzo, Laurent Nguyen, Shari Lennon, Annick Rousseau, Pierre Marquet, Yannick Le Meur, Gilles Paintaud, Étienne Chatelut, M. Büchler and Franck Saint‐Marcoux and has published in prestigious journals such as British Journal of Cancer, Annals of Oncology and European Journal of Cancer.

In The Last Decade

F. Léger

11 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
F. Léger France	10	152	143	125	123	112	11	476
Shari Lennon United States	9	327 2.2×	69 0.5×	49 0.4×	84 0.7×	90 0.8×	11	471
Ami Batchelder United States	11	418 2.8×	130 0.9×	110 0.9×	91 0.7×	29 0.3×	13	692
R VANSCHAIK Netherlands	5	76 0.5×	180 1.3×	98 0.8×	137 1.1×	27 0.2×	6	386
Christophe Gerbeau Switzerland	12	42 0.3×	46 0.3×	282 2.3×	55 0.4×	46 0.4×	27	498
Kjeld Schmiegelow Denmark	7	79 0.5×	116 0.8×	46 0.4×	317 2.6×	24 0.2×	8	829
Wanda Górnik Poland	12	61 0.4×	184 1.3×	21 0.2×	103 0.8×	30 0.3×	25	508
Philippe Thiry Belgium	11	38 0.3×	60 0.4×	125 1.0×	77 0.6×	31 0.3×	18	386
Florent Puisset France	13	48 0.3×	215 1.5×	22 0.2×	58 0.5×	21 0.2×	35	521
Andy Nicholls United Kingdom	8	44 0.3×	39 0.3×	561 4.5×	149 1.2×	43 0.4×	11	778
Olga Bessmertny United States	10	155 1.0×	55 0.4×	37 0.3×	85 0.7×	59 0.5×	17	364

Countries citing papers authored by F. Léger

Since Specialization

Citations

This map shows the geographic impact of F. Léger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Léger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Léger more than expected).

Fields of papers citing papers by F. Léger

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Léger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Léger. The network helps show where F. Léger may publish in the future.

Co-authorship network of co-authors of F. Léger

This figure shows the co-authorship network connecting the top 25 collaborators of F. Léger. A scholar is included among the top collaborators of F. Léger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Léger. F. Léger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Léger, F., Laurent Nguyen, & C. Puozzo. (2009). Exposure equivalence between IV (0.8 mg/kg) and oral (1 mg/kg) busulfan in adult patients. European Journal of Clinical Pharmacology. 65(9). 903–911. 22 indexed citations

Bonneterre, Jacques, M. Campone, Maria Błasińska-Morawiec, et al.. (2006). Vinorelbine/docetaxel combination treatment of metastatic breast cancer: a phase I study. Cancer Chemotherapy and Pharmacology. 60(3). 365–373. 7 indexed citations

Nguyen, Laurent, F. Léger, Shari Lennon, & C. Puozzo. (2005). Intravenous busulfan in adults prior to haematopoietic stem cell transplantation: a population pharmacokinetic study. Cancer Chemotherapy and Pharmacology. 57(2). 191–198. 86 indexed citations

Nguyen, Laurent, et al.. (2004). I.V. busulfan in pediatrics: a novel dosing to improve safety/efficacy for hematopoietic progenitor cell transplantation recipients. Bone Marrow Transplantation. 33(10). 979–987. 111 indexed citations

Rousseau, Annick, F. Léger, Yannick Le Meur, et al.. (2004). Population Pharmacokinetic Modeling of Oral Cyclosporin Using NONMEM. Therapeutic Drug Monitoring. 26(1). 23–30. 75 indexed citations

Léger, F., Walter J. Loos, R. Bugat, et al.. (2004). Mechanism-based models for topotecan-induced neutropenia. Clinical Pharmacology & Therapeutics. 76(6). 567–578. 37 indexed citations

Léger, F., Walter J. Loos, R. Bugat, et al.. (2004). Factors affecting pharmacokinetic variability of oral topotecan: a population analysis. British Journal of Cancer. 90(2). 343–347. 31 indexed citations

Monchaud, Caroline, Annick Rousseau, F. Léger, et al.. (2003). Limited sampling strategies using Bayesian estimation or multilinear regression for cyclosporin AUC0–12 monitoring in cardiac transplant recipients over the first year post-transplantation. European Journal of Clinical Pharmacology. 58(12). 813–820. 27 indexed citations

Etienne, M C, F. Léger, Xavier Pivot, et al.. (2003). Pharmacokinetics of low-dose carboplatin and applicability of a method of calculation for estimating individual drug clearance. Annals of Oncology. 14(4). 643–647. 9 indexed citations

10.

Léger, F., Jean Debord, Yannick Le Meur, et al.. (2002). Maximum A Posteriori Bayesian Estimation of Oral Cyclosporin Pharmacokinetics in Patients with Stable Renal Transplants. Clinical Pharmacokinetics. 41(1). 71–80. 47 indexed citations

11.

Léger, F., Sophie Séronie-Vivien, Isabelle Lochon, et al.. (2002). Impact of the biochemical assay for serum creatinine measurement on the individual carboplatin dosing. European Journal of Cancer. 38(1). 52–56. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact